Showing 2 posts of 2 posts found.
An independent data monitoring committee has told Roche to halt a study of its experimental lung cancer drug MetMab due …
Roche’s MetMab has shown huge promise in phase II trials in lung cancer – but only in patients with ‘high …
Hot-tub therapy tested as potential treatment for peripheral artery disease
Raimond takes helm at Nuclera
Most advanced breast cancer patients treated in community settings, Phesi study finds
Orforglipron shows weight and glucose advantages over oral semaglutide in indirect comparison
Bramacare opens supported-living facility for eating disorder recovery